PT Merck Tbk MERK.JK Stock
PT Merck Tbk Price Chart
PT Merck Tbk MERK.JK Financial and Trading Overview
| PT Merck Tbk stock price | 4010 IDR |
| Previous Close | 4730 IDR |
| Open | 4700 IDR |
| Bid | 4710 IDR x 0 |
| Ask | 4730 IDR x 0 |
| Day's Range | 4700 - 4710 IDR |
| 52 Week Range | 3900 - 5675 IDR |
| Volume | 5.2K IDR |
| Avg. Volume | 45.73K IDR |
| Market Cap | 2.11T IDR |
| Beta (5Y Monthly) | 0.685273 |
| PE Ratio (TTM) | 12.970203 |
| EPS (TTM) | 358.09 IDR |
| Forward Dividend & Yield | 320 (6.79%) |
| Ex-Dividend Date | May 22, 2023 |
| 1y Target Est | N/A |
MERK.JK Valuation Measures
| Enterprise Value | 1.9T IDR |
| Trailing P/E | 12.970203 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.9462734 |
| Price/Book (mrq) | 2.6259422 |
| Enterprise Value/Revenue | 1.751 |
| Enterprise Value/EBITDA | 8.934 |
Trading Information
PT Merck Tbk Stock Price History
| Beta (5Y Monthly) | 0.685273 |
| 52-Week Change | 18.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 5675 IDR |
| 52 Week Low | 3900 IDR |
| 50-Day Moving Average | 4840 IDR |
| 200-Day Moving Average | 4952.18 IDR |
MERK.JK Share Statistics
| Avg. Volume (3 month) | 45.73K IDR |
| Avg. Daily Volume (10-Days) | 37.63K IDR |
| Shares Outstanding | 448M |
| Float | 59.8M |
| Short Ratio | N/A |
| % Held by Insiders | 86.65% |
| % Held by Institutions | 1.36% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 320 |
| Trailing Annual Dividend Yield | 6.76% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.6593 |
| Last Split Factor | 20:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 15.08% |
| Operating Margin (ttm) | 19.69% |
| Gross Margin | 37.34% |
| EBITDA Margin | 19.59% |
Management Effectiveness
| Return on Assets (ttm) | 12.67% |
| Return on Equity (ttm) | 21.01% |
Income Statement
| Revenue (ttm) | 1.08T IDR |
| Revenue Per Share (ttm) | 2420.01 IDR |
| Quarterly Revenue Growth (yoy) | -13.40% |
| Gross Profit (ttm) | 427.59B IDR |
| EBITDA | 212.46B IDR |
| Net Income Avi to Common (ttm) | 163.53B IDR |
| Diluted EPS (ttm) | 363.14 |
| Quarterly Earnings Growth (yoy) | -26.00000000000000000000000000000000% |
Balance Sheet
| Total Cash (mrq) | 226.87B IDR |
| Total Cash Per Share (mrq) | 506.41 IDR |
| Total Debt (mrq) | 14.99B IDR |
| Total Debt/Equity (mrq) | 1.87 IDR |
| Current Ratio (mrq) | 3.978 |
| Book Value Per Share (mrq) | 1793.642 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 124.72B IDR |
| Levered Free Cash Flow (ttm) | 70.27B IDR |
Profile of PT Merck Tbk
| Country | Indonesia |
| State | N/A |
| City | Jakarta Timur |
| Address | Jl. TB Simatupang No. 8 |
| ZIP | 13760 |
| Phone | 62 21 2856 5600 |
| Website | https://www.merckgroup.com/id-id |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 387 |
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing, and marketing pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders comprising hyperthyroidism and hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is headquartered in East Jakarta, Indonesia. PT Merck Tbk is a subsidiary of Merck Holding GmbH.
Q&A For PT Merck Tbk Stock
What is a current MERK.JK stock price?
PT Merck Tbk MERK.JK stock price today per share is 4010 IDR.
How to purchase PT Merck Tbk stock?
You can buy MERK.JK shares on the Jakarta exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for PT Merck Tbk?
The stock symbol or ticker of PT Merck Tbk is MERK.JK.
Which industry does the PT Merck Tbk company belong to?
The PT Merck Tbk industry is Drug Manufacturers-Specialty & Generic.
How many shares does PT Merck Tbk have in circulation?
The max supply of PT Merck Tbk shares is 448M.
What is PT Merck Tbk Price to Earnings Ratio (PE Ratio)?
PT Merck Tbk PE Ratio is 11.19830200 now.
What was PT Merck Tbk earnings per share over the trailing 12 months (TTM)?
PT Merck Tbk EPS is 358.09 IDR over the trailing 12 months.
Which sector does the PT Merck Tbk company belong to?
The PT Merck Tbk sector is Healthcare.
PT Merck Tbk MERK.JK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| IDX COMPOSITE JKSE | 7286.88 IDR 0.47 USD |
+0.45
|
— — | 7239.27 IDR 0.46 USD | 7298.86 IDR 0.47 USD | — - | — — |
- {{ link.label }} {{link}}